Iwamoto et al. compared six distinct assays for breast cancer (MammaPrint, Oncotype DX®, a 76-gene signature assay, mitotic kinase prognostic score, MKI67 mRNA expression, and molecular subtype). The gene discussed is MKI67; the disease is breast carcinoma.